• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加蓬恶性疟原虫对抗疟药敏感性的随访。

Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.

作者信息

Philipps J, Radloff P D, Wernsdorfer W, Kremsner P G

机构信息

Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon.

出版信息

Am J Trop Med Hyg. 1998 May;58(5):612-8. doi: 10.4269/ajtmh.1998.58.612.

DOI:10.4269/ajtmh.1998.58.612
PMID:9598450
Abstract

The sensitivity of Plasmodium falciparum to chloroquine, mefloquine, quinine, quinidine, halofantrine, artemisinin, and sulfadoxine/pyrimethamine was investigated in Lambarene, Gabon in 1994. The development of in vitro susceptibility has been traced from 1983 or 1992 to 1994 for chloroquine, mefloquine, halofantrine, and quinine. Standard in vitro microtests according to World Health Organization methodology were performed. Of 33 isolates tested for susceptibility to chloroquine, 31 were resistant, one was borderline, and one isolate was sensitive (mean 50% effective concentration [EC50] = 1.38 micromol/L of blood). With mefloquine, all isolates were fully inhibited below the threshold of resistance (mean EC50 = 0.51 micrmol/L of blood). Of 32 isolates tested with quinine, six had borderline resistance (mean EC50 = 0.54 micromol/L of blood medium mixture). Susceptibility to quinidine was higher with a mean EC50 of 0.15 micromol/L of blood medium mixture. With halofantrine, 26 of 32 isolates matured at 3 nmol/L of blood medium mixture (mean EC50 = 1.64 nmol/L of blood medium mixture), indicating a steep decrease in susceptibility in comparison with 1992. For artemisinin, the mean EC50 was 97.92 nmol/L of blood medium mixture. Sulfadoxine/pyrimethamine showed five of 16 resistant isolates with a mean EC50 of 2.46 nmol/L of blood medium mixture. Whereas chloroquine resistance remained stable with a tendency to decrease, susceptibility to mefloquine and quinine was slightly decreased. A significant increase in the mean EC50 and EC90 in comparison with our previous data from Gabon was found for halofantrine.

摘要

1994年在加蓬的兰巴雷内对恶性疟原虫对氯喹、甲氟喹、奎宁、奎尼丁、卤泛群、青蒿素和周效磺胺/乙胺嘧啶的敏感性进行了研究。从1983年或1992年至1994年追踪了氯喹、甲氟喹、卤泛群和奎宁体外敏感性的发展情况。按照世界卫生组织的方法进行了标准的体外微量试验。在检测氯喹敏感性的33株分离株中,31株耐药,1株临界,1株敏感(平均50%有效浓度[EC50]=1.38微摩尔/升血液)。对于甲氟喹,所有分离株在耐药阈值以下均被完全抑制(平均EC50=0.51微摩尔/升血液)。在用奎宁检测的32株分离株中,6株有临界耐药(平均EC50=0.54微摩尔/升血液培养基混合物)。对奎尼丁的敏感性较高,平均EC50为0.15微摩尔/升血液培养基混合物。对于卤泛群,32株分离株中有26株在3纳摩尔/升血液培养基混合物中成熟(平均EC50=1.64纳摩尔/升血液培养基混合物),表明与1992年相比敏感性急剧下降。对于青蒿素,平均EC50为97.92纳摩尔/升血液培养基混合物。周效磺胺/乙胺嘧啶在16株耐药分离株中有5株,平均EC50为2.46纳摩尔/升血液培养基混合物。氯喹耐药性保持稳定并有下降趋势,而对甲氟喹和奎宁的敏感性略有下降。与我们之前来自加蓬的数据相比,卤泛群的平均EC50和EC90显著增加。

相似文献

1
Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon.加蓬恶性疟原虫对抗疟药敏感性的随访。
Am J Trop Med Hyg. 1998 May;58(5):612-8. doi: 10.4269/ajtmh.1998.58.612.
2
In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine.坦桑尼亚恶性疟原虫野生分离株对青蒿素、氯喹、周效磺胺/乙胺嘧啶和甲氟喹的体外敏感性
Parasitology. 1997 Jun;114 ( Pt 6):503-6.
3
Susceptibility of Plasmodium falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/pyrimethamine in Somalia: relationships between the responses to the different drugs.索马里恶性疟原虫体外对氯喹、甲氟喹、奎宁和磺胺多辛/乙胺嘧啶的敏感性:不同药物反应之间的关系
Trans R Soc Trop Med Hyg. 1991 Sep-Oct;85(5):565-9. doi: 10.1016/0035-9203(91)90343-w.
4
Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials.
Trop Med Parasitol. 1994 Sep;45(3):214-8.
5
In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.柬埔寨恶性疟原虫分离株对卤泛群、咯萘啶和青蒿素衍生物的体外敏感性
Ann Trop Med Parasitol. 1994 Apr;88(2):137-44. doi: 10.1080/00034983.1994.11812851.
6
In-vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar.马达加斯加恶性疟原虫对氯喹、卤泛群、甲氟喹和奎宁的体外敏感性
East Afr Med J. 2002 May;79(5):237-41.
7
In vitro sensitivity of Plasmodium falciparum to halofantrine compared with chloroquine, quinine and mefloquine in the region of Bobo-Dioulasso, Burkina Faso (West Africa).在布基纳法索(西非)博博迪乌拉索地区,恶性疟原虫对卤泛群与氯喹、奎宁和甲氟喹的体外敏感性比较
Trop Med Int Health. 1998 May;3(5):381-4.
8
In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum.青蒿素衍生物对恶性疟原虫非洲分离株和克隆株的体外活性。
Am J Trop Med Hyg. 1993 Sep;49(3):301-7. doi: 10.4269/ajtmh.1993.49.301.
9
Assessment of susceptibility of Plasmodium falciparum to chloroquine, quinine, mefloquine, sulfadoxine-pyrimethamine and artemisinin in southern Viet Nam.越南南部恶性疟原虫对氯喹、奎宁、甲氟喹、磺胺多辛-乙胺嘧啶和青蒿素敏感性的评估。
Trans R Soc Trop Med Hyg. 2001 Sep-Oct;95(5):513-7. doi: 10.1016/s0035-9203(01)90023-9.
10
In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum.氯喹、奎宁、甲氟喹和卤泛群对加蓬恶性疟原虫分离株的体外活性。
Trop Med Int Health. 2003 Jan;8(1):25-9. doi: 10.1046/j.1365-3156.2003.00967.x.

引用本文的文献

1
Antimalarial Drug Resistance: A Threat to Malaria Elimination.抗疟药物耐药性:对疟疾消除的威胁。
Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a025619. doi: 10.1101/cshperspect.a025619.
2
In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.法国滨海省(加蓬)体外抗疟药物敏感性及耐药相关分子标志物研究
BMC Infect Dis. 2012 Nov 15;12:307. doi: 10.1186/1471-2334-12-307.
3
Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.
磷酸氟喹在无症状疟原虫感染者中的药代动力学。
Antimicrob Agents Chemother. 2012 Jun;56(6):3165-73. doi: 10.1128/AAC.05359-11. Epub 2012 Mar 19.
4
In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.咯萘啶对恶性疟原虫的体外活性及抗疟药物敏感性试验的比较评价
Malar J. 2009 Apr 23;8:79. doi: 10.1186/1475-2875-8-79.
5
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs.手性抗疟药物的药效学和药代动力学中的立体选择性。
Clin Pharmacokinet. 2003;42(15):1359-82. doi: 10.2165/00003088-200342150-00004.
6
In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum.克林霉素与双氢青蒿素联合对恶性疟原虫的体外活性及相互作用
Antimicrob Agents Chemother. 2003 Nov;47(11):3494-9. doi: 10.1128/AAC.47.11.3494-3499.2003.
7
Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.加蓬患者中Pfmdr1等位基因与超低剂量甲氟喹治疗反应
Antimicrob Agents Chemother. 2002 Jan;46(1):166-70. doi: 10.1128/AAC.46.1.166-170.2002.